Growth Opportunities for Clinical Laboratory Services in Asia-Pacific

Growth Opportunities for Clinical Laboratory Services in Asia-Pacific

Proliferation of High-end Specialized Testing and Interconnected Lab Networks Fuel Growth Potential

RELEASE DATE
19-Sep-2023
REGION
North America
Deliverable Type
Market Research
Research Code: PEB4-01-00-00-00
SKU: CM_2023_152
AvailableYesPDF Download

$4,950.00

Special Price $4,455.00 save 10 %

In stock
SKU
CM_2023_152

Growth Opportunities for Clinical Laboratory Services in Asia-Pacific
Published on: 19-Sep-2023 | SKU: CM_2023_152

Need more details?

$4,950.00

$4,455.00save 10 %

DownloadLink
Need more details?

Clinical labs are the foundation of the healthcare ecosystem. This research overviews the Asia-Pacific (APAC) clinical laboratory services industry for the period 2022–2028. Country-specific and vertical-specific forecasts are provided from 2023 to 2028 using a base year of 2022. Frost & Sullivan focused on APAC following various events unfolding from the COVID-19 pandemic. Today, health systems are building a preventive and sustainable ecosystem. Because of waning opportunities in COVID-19 testing, labs across the industry focus on tackling an excess capacity in analyzers. This dynamic is leading to innovative services becoming more widespread for consumers.

The industry comprises two disciplines: pathology and radiology/diagnostic imaging. This study focuses on pathology lab testing services and does not include contract research organizations, food/feed testing, diagnostic imaging, or digital pathology services. The pathology lab testing segment breaks down into routine and specialized (high-end specialized and semi-specialized) testing services. The competitive environment covers hospital labs and independent labs, including multi-chain organized and unorganized labs. This study concludes with a discussion of four growth opportunities industry players should consider to build on trends, maximize economic potential, and sustain value.

Author: Amartya Bose

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Asia-Pacific (APAC) Clinical Laboratory Services Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Scope of Analysis (continued)

Segmentation by Testing Services

Segmentation by Service Provider

Key Competitors

Growth Metrics

Growth Drivers

Growth Drivers (continued)

Growth Restraints

Growth Restraints (continued)

Growth Restraints (continued)

Forecast Assumptions

Forecast Assumptions (continued)

Revenue Forecast

Revenue Forecast by Industry Vertical

Revenue Forecast by Country

Revenue Forecast Analysis

Revenue Forecast Analysis (continued)

Revenue Forecast Analysis (continued)

Revenue Forecast Analysis (continued)

Revenue Forecast Analysis (continued)

Pricing Trends and Forecast Analysis

Pricing Trends and Forecast Analysis (continued)

Competitive Environment

Revenue Share

Revenue Share Analysis

Revenue Share Analysis (continued)

Growth Metrics

Revenue Forecast

Revenue Forecast by Country

Forecast Analysis

Forecast Analysis (continued)

Growth Metrics

Revenue Forecast

Revenue Forecast by Country

Forecast Analysis

Forecast Analysis (continued)

Growth Opportunity 1—High-end Specialized Testing Services

Growth Opportunity 1—High-end Specialized Testing Services (continued)

Growth Opportunity 2—At-home Testing Services

Growth Opportunity 2—At-home Testing Services (continued)

Growth Opportunity 3—Diagnostic Network Optimization

Growth Opportunity 3—Diagnostic Network Optimization (continued)

Growth Opportunity 4—Digital Solutions

Growth Opportunity 4—Digital Solutions (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Clinical labs are the foundation of the healthcare ecosystem. This research overviews the Asia-Pacific (APAC) clinical laboratory services industry for the period 2022–2028. Country-specific and vertical-specific forecasts are provided from 2023 to 2028 using a base year of 2022. Frost & Sullivan focused on APAC following various events unfolding from the COVID-19 pandemic. Today, health systems are building a preventive and sustainable ecosystem. Because of waning opportunities in COVID-19 testing, labs across the industry focus on tackling an excess capacity in analyzers. This dynamic is leading to innovative services becoming more widespread for consumers. The industry comprises two disciplines: pathology and radiology/diagnostic imaging. This study focuses on pathology lab testing services and does not include contract research organizations, food/feed testing, diagnostic imaging, or digital pathology services. The pathology lab testing segment breaks down into routine and specialized (high-end specialized and semi-specialized) testing services. The competitive environment covers hospital labs and independent labs, including multi-chain organized and unorganized labs. This study concludes with a discussion of four growth opportunities industry players should consider to build on trends, maximize economic potential, and sustain value. Author: Amartya Bose
More Information
Deliverable Type Market Research
Author Amartya Bose
Industries Chemicals and Materials
No Index No
Is Prebook No
Keyword 1 Clinical Laboratory Services
Keyword 2 Diagnostic Lab Services
Keyword 3 Medical Diagnostics In Asia-Pacific
Podcast No
WIP Number PEB4-01-00-00-00